Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Ramses F Sadek is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Radiation Therapy Oncology Group-Statistical Center
Sadek, R. F. (PI), Pajak, T. F. (CoPI), Scott, C. B. (CoPI) & Swann, S. R. (CoPI)
4/1/85 → 12/31/08
Project: Research project
-
Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2
Brown, Z., Scott, C., Zhang, L. F., Sadek, R., Clarke, A., Jillella, A., Keruakous, A. R. & Clemmons, A. B., Sep 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 9, p. 642-647 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Effect of indoximod-based chemo-immunotherapy in patients with pediatric brain tumors on activation and clonal proliferation of a circulating population of early non-exhausted stem-like CD8+ T cells whose on-treatment expansion is predictive of long-term outcome.
Pacholczyk, R., Satpathy, S., Berrong, Z., Chien, F., Huang, C., Sadek, R. F., Thomas, B. E., Smith, C., MacDonald, T. J., Kennedy, E. P., Johnson, T. S., Bhasin, M. K. & Munn, D. H., Jun 2024, In: Journal of Clinical Oncology. 42, p. 2566 1 p.Research output: Contribution to journal › Review article › peer-review
-
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
Johnson, T. S., MacDonald, T. J., Pacholczyk, R., Aguilera, D., Al-Basheer, A., Bajaj, M., Bandopadhayay, P., Berrong, Z., Bouffet, E., Castellino, R. C., Dorris, K., Eaton, B. R., Esiashvili, N., Fangusaro, J. R., Foreman, N., Fridlyand, D., Giller, C., Heger, I. M., Huang, C. & Kadom, N. & 18 others, , Feb 1 2024, In: Neuro-Oncology. 26, 2, p. 348-361 14 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC
Caraballo Galva, L. D., Jiang, X., Hussein, M. S., Zhang, H., Mao, R., Brody, P., Peng, Y., He, A. R., Kehinde-Ige, M., Sadek, R., Qiu, X., Shi, H. & He, Y., Aug 2022, In: Hepatology. 76, 2, p. 330-344 15 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations -
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center
Kreidieh, F., Sadek, R. F., Zhang, L. F., Gopal, A., Blaize, J. P., Yashar, D., Patel, R., Patel, H. S., Tang, S. C. & Sater, H. A., 2022, In: JCO Precision Oncology. 6, e2100201.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations